Searching for responders to acamprosate and naltrexone in alcoholism treatment: Rationale and design of the predict study

Alcoholism: Clinical and Experimental Research

Volumn 33, Issue 4, 2009, Pages 674-683

  Mann, Karl ^a   Kiefer, Falk ^a   Smolka, Michael ^a,b   Gann, Horst ^c   Wellek, Stefan ^a   Heinz, Andreas ^d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Alcohol Dependence; Behavioral Intervention; Pharmacotherapy; Predictor; RCT

Indexed keywords

ACAMPROSATE; NALTREXONE;

ADULT; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOUBLE BLIND PROCEDURE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; STARTLE REFLEX; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ALCOHOL DETERRENTS; ALCOHOLISM; COMBINED MODALITY THERAPY; DOPAMINE AGENTS; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID AGENTS; FEMALE; GERMANY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NALTREXONE; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PSYCHOTHERAPY; REFLEX; TAURINE; UNITED STATES; YOUNG ADULT;

EID: 63149094128     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2008.00884.x     Document Type: Article

References (68)

1. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A, COMBINE Study Research Group (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295 : 2003 2017.
2. Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H, Goldman D (2008) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 65 : 135 144.
3. Anton RE, Randall CL (2005) Measurement and choice of drinking outcome variables in the COMBINE Study. J Stud Alcohol 15 : 104 109.
4. Barr CS, Schwandt M, Lindell SG, Chen SA, Goldman D, Suomi SJ, Higley JD, Heilig M (2007) Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques. Arch Gen Psychiatry 64 : 369 376.
5. Berglund M, Thelander S, Salaspuro M, Franck J, Andreasson S, Ojehagen A (2003) Treatment of alcohol abuse: an evidence-based review. Alcohol Clin Exp Res 27 : 1645 1656.
6. Bradley MM, Cuthbert BN, Lang PJ (1990) Startle reflex modification: emotion or attention? Psychophysiology 27 : 513 522.
7. Brueck G, Mann K (2006) Alcohol-Specific Psychotherapy: Manual with Treatment Modules [Alkoholismusspezifische Psychotherapie: Manual mit Behandlungs-modulen]. Deutscher Ärzte Verlag, Koeln.
8. Carter BL, Tiffany ST (1999) Meta-analysis of cue-reactivity in addiction research. Addiction 94 : 327 340.
9. Chick J, Howlett H, Morgan MY, Ritson B (2000) United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol Alcohol 35 : 176 187.
10. COMBINE Study Research Group (2003a) Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study. Alcohol Clin Exp Res 27 : 1123 1131.
11. COMBINE Study Research Group (2003b) Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods. Alcohol Clin Exp Res 27 : 1107 1122.
12. Cox DR (1972) Regression models and life-tables. J Roy Statist Soc B 34 : 187 220.
13. De Witte P (2004) Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol. Addict Behav 29 : 1325 1339.
14. DiClemente CC, Carbonari JP, Montgomery RP, Hughes S (1994) The alcohol abstinence self-efficacy scale. J Stud Alcohol 55 : 141 148.
15. Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT (1999) Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 281 : 1318 1325.
16. Gastpar M, Bonnet U, Boening J, Mann K, Schmidt LG, Soyka M, Wetterling T, Kielstein V, Labriola D, Croop R (2002) Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study. J Clin Psychopharmacol 22 : 592 598.
17. Geier A, Mucha RF, Pauli P (2000) Appetitive nature of drug cues confirmed with physiological measures in a model using pictures of smoking. Psychopharmacology 150 : 283 291.
18. Glöckner-Rist A, Hotijtink H (2003) The best of both worlds: factor analysis of dichotomous data using item response theory and structural equation modelling. Structural Equation Modeling 10 : 544 565.
19. Grüsser SM, Heinz A, Raabe A, Wessa M, Podschus J, Flor H (2002) Stimulus-induced craving and startle potentiation in abstinent alcoholics and controls. Eur Psychiatry 17 : 188 193.
20. Grüsser SM, Wrase J, Klein S, Hermann D, Smolka MN, Ruf M, Weber-Fahr W, Flor H, Mann K, Braus DF, Heinz A (2004) Cue-induced activation of the striatum and medial prefrontal cortex predicts relapse in abstinent alcoholics. Psychopharmacology 175 : 296 302.
21. Heinz A, Löber S, Georgi A, Wrase J, Hermann D, Rey ER, Wellek S, Mann K (2003) Reward craving and withdrawal relief craving: assessment of different motivational pathways to alcohol intake. Alcohol Alcohol 38 : 35 39.
22. Heinz A, Reimold M, Wrase J, Hermann D, Croissant B, Mundle G, Dohmen BM, Braus DH, Schumann G, Machulla HJ, Bares R, Mann K (2005) Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry 62 : 57 64.
23. Hoelter SM, Spanagel R (1999) Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology 145 : 360 369.
24. Hosking JD, Cisler RA, Couper DJ, Gastfriend DR, Kivlahan DR, Anton RF (2005) Design and analysis of trials of combination therapies. J Stud Alcohol 15 : 34 42.
25. Kiefer F, Helwig H, Tarnaske T, Otte C, Jahn H, Wiedemann K (2005) Pharmacological relapse prevention of alcoholism: clinical predictors of outcome. Eur Addict Res 11 : 83 91.
26. Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Kampf P, Stracke R, Baehr M, Naber D, Wiedemann K (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 60 : 92 99.
27. Koob GF (2003) Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 27 : 232 243.
28. Koob GF, Le Moal M (2008) Addiction and the brain antireward system. Annu Rev Psychol 59 : 29 53.
29. Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA (2001) Naltrexone in the treatment of alcohol dependence. N Engl J Med 345 : 1734 1739.
30. Krystal JH, Webb E, Grillon C, Cooney N, Casal L, Morgan CA III., Southwick SM, Davis M, Charney DS (1997) Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: modulation by yohimbine and m- chlorophenylpiperazine (mCPP). Psychopharmacology 131 : 207 215.
31. Lang PJ, Bradley MM, Cuthbert BN (1990) Emotion, attention, and the startle reflex. Psychol Rev 97 : 377 395.
32. Leménager T (2008) Operationalization of different craving dimensions and validation of Psychological and neuropsychological criteria [Operationalisierung differenter Craving Dimensionen und Validierung an psychologischen sowie neurophysiologischen Kriterien]. Dissertation, Central Institute of Mental Health, University of Heidelberg, Heidelberg.
33. Littleton J (1995) Acamprosate in alcohol dependence: how does it work? Addiction 90 : 1179 1188.
34. Mann KF (2004) Pharmacotherapy of alcohol dependence: a review of the clinical data. CNS Drugs 18 : 485 504.
35. Mann K, Agartz I, Harper C, Shoaf S, Rawlings RR, Momenan R, Hommer DW, Pfefferbaum A, Sullivan EV, Anton RF, Drobes DJ, George MS, Bares R, Machulla HJ, Mundle G, Reimold M, Heinz A (2001) Neuroimaging in alcoholism: ethanol and brain damage. Alcohol Clin Exp Res 25 : 104 109.
36. Mann K, Kiefer F, Spanagel R, Littleton J (2008) Acamprosate: recent findings and future research directions. Alcohol Clin Exp Res 32 : 1105 1110.
37. Mann K, Lehert P, Morgan MY (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res 28 : 51 63.
38. Mann K, Loeber S, Croissant B, Kiefer F (2006) Qualified Detoxification of Alcohol-Dependent Patients: A Manual for the Pharmaco- and Psychotherapy [Qualifizierte Entzugsbehandlung von Alkoholabhängigen: Ein Manual zur Pharmako-und Psychotherapie]. Deutscher Ärzte Verlag, Koeln.
39. Mason BJ, Goodman AM, Chabac S, Lehert P (2006) Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. J Psychiatr Res 40 : 383 393.
40. Miller WR, Movers TB, Arciniega L, Ernst D, Forcehimes A (2005) Training, supervision and quality monitoring of the COMBINE Study behavioral interventions. J Stud Alcohol Suppl 15 : 188 195.
41. Mucha RF, Geier A, Stuhlinger M, Mundle G (2000) Appetitve effects of drug cues modelled by pictures of the intake ritual: generality of cue-modulated startle examined with inpatient alcoholics. Psychopharmacology 151 : 428 432.
42. Myrick H, Anton R, Xingbao L, Henderson S, Randall PK, Voronin K (2008) Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry 65 : 466 475.
43. Nakovics H, Leménager T, Diehl A, Zimmermann U, Reinhard I, Mann K (2008) Validation of the IDS (Inventory of Drinking Situations) to individualize the treatment of alcohol dependence [Validierung des IDS zur Individualisierung der Alkoholabhängigkeits-behandlung]. SUCHT 54 : 3, 183.
44. O'Brien CP, Childress AR, Ehrman R, Robbins SJ (1998) Conditioning factors in drug abuse: can they explain compulsion? J Psychopharmacol 12 : 15 22.
45. O'Malley SS, Jaffe AJ, Chang G, Rode S, Schottenfeld R, Meyer RE, Rounsaville B (1996) Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry 53 : 217 224.
46. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacol 28 : 1546 1552.
47. Pettinati HM, Weiss RD, Miller WR, Donovan D, Ernst DB, Rounsaville BJ (2004) Medical Management (MM) Treatment Manual. National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
48. Project MATCH Research Group (1997) Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol 58 : 7 29.
49. Rassnick S, Koob GF, Geyer MA (1992) Responding to acoustic startle during chronic ethanol intoxication and withdrawal. Psychopharmacol 106 : 351 358.
50. Rist F, Carrie L, Randall L, Heather N, Mann K (2005) New developments in alcoholism treatment research in Europe. Alcoholism Clin & Exp Res 29 : 1127 1132.
51. Sass H, Soyka M, Mann K, Zieglgänsberger W (1996) Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry 53 : 673 680.
52. Schoenfeld DA (1981) The asymptotic properties of nonparametric tests for comparing survival distributions. Biometrika 68 : 316 319.
53. Solomon RL (1980) The opponent-process theory of acquired motivation: the costs of pleasure and the benefits of pain. Am Psychol 35 : 691 712.
54. Spanagel R, Kiefer F (2008) Drugs for relapse prevention of alcoholism: ten years of progress. Trends in Pharm Scienc 29 : 109 115.
55. Spanagel R, Weiss F (1999) The dopamine hypothesis of reward: past and current status. Trends Neurosci 22 : 521 527.
56. Srisurapanont M, Jarusuraisin N (2005) Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol 8 : 267 280.
57. Stewart SH, Samoluk SB, Conrod PJ, Pihl RO, Dongier M (2000) Psychometric evaluation of the short form inventory of drinking situations (IDS-42) in a community-recruited sample of substance-abusing women. J Subst Abuse 11 : 305 321.
58. Streeton C, Whelan G (2001) Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials. Alcohol Alcohol 36 : 544 552.
59. Swift RM (1999) Drug therapy for alcohol dependence. N Engl J Med 340 : 1482 1490.
60. Tiffany ST (1990) A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychol Rev 97 : 147 168.
61. Tiffany ST, Conklin CA (2000) A cognitive processing model of alcohol craving and compulsive alcohol use. Addiction 95 (Suppl. 2 S145 S153.
62. Verheul R, Lehert P, Geerlings PJ, Koeter MW, van den Brink W (2005) Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients. Psychopharmacology 178 : 167 173.
63. Verheul R, van den BW, Geerlings P (1999) A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol 34 : 197 222.
64. Victorio-Estrada A, Mucha RF (1997) The Inventory of Drinking Situations (IDS) in current drinkers with different degrees of alcohol problems. Addict Behav 22 : 557 565.
65. Victorio-Estrada A, Mucha RF, Stephan ER (1996) Excessive drinking situations in German alcoholics: replication of a three-factor model used for North Americans. Drug Alcohol Depend 41 : 75 79.
66. Volpicelli JR, Clay KL, Watson NT, O'Brien CP (1995) Naltrexone in the treatment of alcoholism: predicting response to naltrexone. J Clin Psychiatry 56 : 39 44.
67. Vrana SR, Spence EL, Lang PJ (1988) The startle probe response: a new measure of emotion? J Abnorm Psychol 97 : 487 491.
68. Weerts EM, Kim YK, Wand GS, Dannals RF, Lee JS, Frost JJ, McCaul ME (2008) Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects. Neuropsychopharmacology 33 : 653 665.